Safety of Corticosteroid Treatment in Rheumatologic Patients With Markers of Hepatitis B Viral Infection: Pilot Evaluation Study.

BackgroundImmunosuppressive agents may induce hepatitis B flares. The minimal corticosteroid dose and duration of therapy leading to HBV reactivation is unknown.ObjectiveTo assess whether short-term corticosteroid therapy for rheumatologic diseases induces HBV reactivation.MethodsThe records of all